Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Bitget Delivers Critical Aid to Earthquake-Affected Families in Myanmar
-
JDE Peet’s share buyback periodic update May 12, 2025
-
Allarity Therapeutics Announces Participation in Pharma Partnering Summit US
-
STMicroelectronics Announces Status of Common Share Repurchase Program
-
ASML reports transactions under its current share buyback program
-
ProQR Announces Upcoming Scientific Presentations at ASGCT and TIDES Conferences
-
ProStar and JAVAD GNSS Announce a Global Partnership to Deliver Precision Mapping Technology to the Utility Industry
-
Director/PDMR Shareholding
-
LNG Energy Group Announces Cease Trade Order
-
Neinor completes strategic monetization of BTR portfolio, unlocking c.€325mn since 2023
-
Transactions under Novonesis’ share buyback program
-
Own shares – Sydbank A/S
-
HUB Cyber Security Expands Cybersecurity Practice with Strategic Client Wins Across Regulated Sectors
-
Paris Steak Brought Elevated Steak Sandwiches to Liberty Village on May 5
-
Imperial Reports First Quarter 2025 Financial Results
-
Trading by management and close relations of management
-
Alterity Therapeutics Prominently Featured at the International MSA Congress
-
Aclarion Announces Texas Back Institute as New CLARITY Trial Site
-
Inter&Co Inc. Reports Year-Over-Year Net Income Growth of 57%
-
Inter&Co Inc. Reports Year-Over-Year Net Income Growth of 57%
-
Clearmind Medicine Announces Publication of European Patent for Psychedelic-Based Combination Therapy for Cocaine Addiction
-
SciSparc-Clearmind Collaboration Leads to Publication of European Patent for Psychedelic-Based Combination Therapy for Cocaine Addiction
-
Solo Brands, Inc. Announces First Quarter 2025 Results
-
HOT DADS WANTED: Habit Burger & Grill X UFC GYM Launch Bold Search for the Hottest Dads in America for Summer Calendar
-
Purple Biotech Appoints Shai Lankry as Chief Financial Officer
-
Surgery Partners, Inc. Announces First Quarter 2025 Results; Reaffirms Full Year 2025 Guidance
-
ProMIS Neurosciences Announces First Quarter 2025 Financial Results
-
Purple Biotech Appoints Shai Lankry as Chief Financial Officer
-
Gain Therapeutics Presents Preclinical Data at IAPRD 2025 30th World Congress on Parkinson’s Disease and Related Disorders
-
PyroGenesis Closes $2,385,000 First Tranche in Previously Announced Loan
-
HOT DADS WANTED: Habit Burger & Grill X UFC GYM Launch Bold Search for the Hottest Dads in America for Summer Calendar
-
Abeona Therapeutics® Enters into Agreement to Sell Priority Review Voucher for $155 Million
-
Bread Financial’s 2024 Sustainability Report showcases focus, investment in sustainable business practices
-
BridgeBio to Present Clinical Outcomes, Quality of Life Measures and Incidence of Atrial Fibrillation Events in Patients with ATTR-CM from the ATTRibute-CM Study at the Annual Congress of the Heart Fa
-
Summary of Tallinna Sadam webinars
-
Farmasiet, Norway’s largest online pharmacy, signs Agillic for advanced customer engagement
-
Longeveron® Named XPRIZE Healthspan Semifinalist and Top 40 Milestone 1 Award Recipient
-
Annual Report for the year ended 31 December 2024 and Notice of Meeting
-
To mark Mental Health Awareness month Swiss CEOs call for putting mental health on the table. Silence about mental health issues costs companies billions
-
Emerging Markets Report: A Milestone for Mycelium
-
Curium receives marketing authorization in Switzerland for PYLCLARI® – an innovative 18F-PSMA PET tracer indicated in patients with prostate cancer
-
Gilat Expands and Adds to its ESA Antenna Portfolio with a Successful Test Flight of ESR-2030Ku on Eutelsat OneWeb Low Earth Orbit (LEO) Network
-
ProVen VCT plc: Issue of Equity
-
Abcourt intersects 3.7 g/t gold over 11 metres directly below the Cartwright stripping and publishes a summary of the 2025 drilling campaign on its Flordin property in the Lebel-Sur-Quévillon area
-
Dorel Reports First Quarter 2025 Financial Results
-
TensorStax Raises $5M to Build Deterministic AI Agents for Data Engineers
-
Invivyd Announces New Pipeline Discovery Program Focused on Monoclonal Antibody Treatment for Measles
-
Sportradar Reports First Quarter Results
-
Metsera Reports First Quarter 2025 Financial Results and Continued Portfolio Progress
-
New Wave Announces Shares for Debt Settlements
